|
The Director, Patient Recruitment and Retention (R&R)is responsible for the development of patient recruitment and retention strategies and tactics that meet the unique needs of BlueRock clinical studies, programs and the patients we serve. This individual will ensure the collection of patient and clinical insights, application to clinical trial planning and execution, the identification and management of niche vendors to support patient-centric trial collateral and communications and the oversight and management of patient inquiries. This leader will also ensure that metrics, analytics and key performance indicators are established, monitored, communicated and leveraged to inform
adjustments to optimally deliver on recruitment and retention goals.
The incumbent will act as an R&R champion and subject matter expert and must effectively collaborate with key stakeholders and matrix teams (including but not limited to Clinical Development, Clinical Operations, Patient Advocacy, CRO's and partners in and outside of BlueRock) to ensure high impact implementation. The ability to influence, collaborate and innovate in order to meet short and long term organizational goals is key.
Responsibilities:
- Together with internal stakeholders and senior Clinical Operations leadership, develop and evolve R&R tools and best practices.
- Collaborate to incorporate patient perspectives and insights into decision-making processes and clinical program and trial planning and execution. This may include assisting in the design of Patient Advisory Group activities (surveys, meetings, etc).
- Lead the development and design recruitment and retention strategies appropriate for the indication, study design, geography and study phase.
- Support and educate stakeholders on options for patient recruitment and retention.
- Collaborate with teams and individuals supporting trial planning and conduct to ensure robust implementation of tactics and tools to meet the needs of our clinical sites.
- Actively manage R&R vendors to ensure the conduct and delivery of services in accordance with contractual requirements, organizational and patient and career needs.
- Propose and implement metrics/analytics/KPIs to track engagements and performance of clinical trial recruitment and retention efforts. Collaborate with leadership and the organization on reporting.
- Champion diversity enrollment and enrichment efforts to attract broad patient populations-for example, people of different races, ethnic groups, sex/genders, and ages.
- Establish and evolve expertise on industry and patient best practices.
Qualifications:
- Bachelor's degree, or equivalent, in a life-science, scientific discipline, medical and / or communication or business studies.
- Minimum of 10 years industry experience in biotech/pharma, CRO or relevant vendor settings with a minimum of 5 years direct experience in patient recruitment, engagement and trial optimization planning in addition to a minimum of 5 years' experience across a broad range of therapeutic areas in clinical operations and strategy settings.
- Data driven mindset including the ability to access and interpret disease related data and information to inform planning.
- Experience identifying and managing niche R&R service providers, developing and overseeing reporting to proactively manage performance and return on investment (ROI).
- Excellent written and spoken language communication skills. Ability to produce high quality reports, project plans and presentations
- Well-developed negotiation skills with the ability to liaise successfully with senior management, clinical project teams, as well as to influence and present to both small and large groups.
- Highly developed organizational, problem solving and analytical skills, with the ability to prioritize time-sensitive tasks and work independently, and to make decision and to progress projects.
- Demonstrated ability to successfully deliver in a fast paced and fluid settings with complex stakeholder networks.
- Specific therapeutic experience in Neurology and Ophthalmology is desirable.
#LI-AL1
|
BlueRock Therapeutics
Jul 30, 2025